dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2) (clinicaltrials.gov) - Mar 7, 2024 - P3 | N=350 | Recruiting | Sponsor: Oculis | Not yet recruiting ➔ Recruiting 
Enrollment open • Diabetic Macular Edema • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT06172257
 
Mar 7, 2024
 
Prev Next